Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Milk thistle: Silybum marianum.

× No keyword cloud information.

18 in total

1. Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability.

Authors: Xinru Li; Quan Yuan; Yanqing Huang; Yanxia Zhou; Yan Liu
Journal: AAPS PharmSciTech Date: 2010-04-20 Impact factor: 3.246

2. Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs.

Authors: Seung-Ki Chon; Nam-Soo Kim
Journal: Parasitol Res Date: 2005-09-09 Impact factor: 2.289

3. Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride.

Authors: Nouf M Al-Rasheed; Nawal M Al-Rasheed; L M Faddah; Azza M Mohamed; Raeesa A Mohammad; Maha Al-Amin
Journal: Saudi J Biol Sci Date: 2013-09-17 Impact factor: 4.219

4. Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study.

Authors: Ali Momeni; Ali Hajigholami; Shohreh Geshnizjani; Soleiman Kheiri
Journal: J Clin Diagn Res Date: 2015-04-01

5. High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin.

Authors: J M Pérez-Victoria; F J Pérez-Victoria; G Conseil; M Maitrejean; G Comte; D Barron; A Di Pietro; S Castanys; F Gamarro
Journal: Antimicrob Agents Chemother Date: 2001-02 Impact factor: 5.191

6. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.

Authors: Ruyue Lian; Yi Lu; Jianping Qi; Yanan Tan; Mengmeng Niu; Peipei Guan; Fuqiang Hu; Wei Wu
Journal: AAPS PharmSciTech Date: 2011-09-23 Impact factor: 3.246

Review 7. The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review.

Authors: Leila Azhar Shekoufeh Bahari; Hamed Hamishehkar
Journal: Adv Pharm Bull Date: 2016-06-30

Review 8. The use of silymarin in the treatment of liver diseases.

Authors: R Saller; R Meier; R Brignoli
Journal: Drugs Date: 2001 Impact factor: 9.546

Review 9. Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review).

Authors: Mudit Vaid; Santosh K Katiyar
Journal: Int J Oncol Date: 2010-05 Impact factor: 5.650

10. Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats.

Authors: Pragada Rajeswara Rao; Routhu Kasi Viswanath
Journal: Exp Clin Cardiol Date: 2007